Cultivating Innovative AI Solutions to Enhance Patient Care

Frontline Caregivers and Staff at Cedars-Sinai Hold ‘Idea-Thons’ to Explore, Develop and Adopt Generative AI Healthcare Tools

As the use of artificial intelligence continues to rapidly evolve, Cedars-Sinai is tapping its own experts to create and deploy AI-driven solutions to real-time healthcare challenges.

Through new “Idea-thons,” frontline clinical and administrative leaders and AI experts across the organization come together to cultivate ideas for using AI to enhance patient care, administrative systems and employee wellbeing. Participants then present their ideas to senior leaders, who vote on which projects to advance, support and, eventually, put into use across the organization.

“Idea-thons empower our frontline caregivers and staff to shape the future of healthcare, and hands-on experience to craft tailored solutions for patients and the organization,” said Craig Kwiatkowski, PharmD, senior vice president and chief information officer at Cedars-

Matthew Bloom, Md,
Matthew Bloom, MD, at a recent Idea-thon

Matthew Bloom, MD, at a recent Idea-thon,  “We are leaning in to create our own road map of imaginative projects using generative AI technologies, centered on enhancing patient care and organizational efficiency.”

The Idea-thons are driven by Cedars-Sinai’s Artificial Intelligence Council, which is charged with guiding and coordinating the organization’s AI strategy. Cedars-Sinai’s AI strategy is built on three strategic pillars: investing and planning, transitioning innovation into adoption, and supporting the ethical, responsible, and scientifically sound use of AI, including generative AI.

Generative AI is a type of artificial intelligence that can create a series of outputs—like video, audio or texts—in response to human requests. These generative AI systems are based on language models like ChatGPT that can be trained to generate content.

The first Idea-thon, in June, brought together more than a dozen physicians from various medical specialties, including cardiology, emergency medicine, surgery, OB-GYN and primary care, as well as AI experts in data science, computational biomedicine and technology.

The session produced solutions with themes centered around care coordination, triage, medication management, communications and clinical trial recruitment. Some of the projects potentially overlapped with initiatives already underway at Cedars-Sinai. Others presented fresh opportunities to develop anew.

“These novel projects can be used alongside our customized generative AI tools and technologies within our health system,” said Mike Thompson, vice president of Enterprise Data Intelligence, who works with Kwiatkowski to steer the organization’s AI strategy.

Thompson said the Idea-thons are informed by the experience and wisdom of frontline healthcare clinicians and other Cedars-Sinai staff who understand firsthand the problems encountered in the delivery of healthcare.

“Our physicians and medical teams have direct insight into the roadblocks within their daily jobs,” Thompson said. “By bringing them into the discussion on generative AI technologies, they can help identify meaningful solutions to these hurdles—which will likely improve patient care, advance the frontiers of medical research and increase organizational efficiency.”

As these ideas transition into tangible solutions, Cedars-Sinai is dedicated to conducting rigorous testing and impact assessments to ensure alignment with the organization’s mission to deliver the highest-quality care. The collaborative teams involved in the Idea-thons aim to refine and tailor AI solutions to address the unique needs of both patients and the organization, while remaining steadfast to their strategic principles.

The next Idea-thon, scheduled for October, will bring together an even broader group of healthcare professionals, including nurses, pharmacists and other clinicians. Another session will follow to include administrative and operational staff from Finance, Human Resources and other departments.

“We are truly inspired by the ingenuity of our staff and by the potential of the generative AI ideas we’ve heard,” Kwiatkowski said. “There are limitless opportunities for innovation within patient care, operational and administrative areas. We will continue listening to and seeking input from our frontline staff as we further explore how to best use these new tools.”

Hot this week

Avery Dennison Medical Introduces Ipdated SilFoam Lite: Sustainability, MDR Certification & Performance Improvements

The newly enhanced SilFoam Lite delivers superior efficiency and reliability, bringing improved fluid handling capabilities and improved tack. These improvements make the product ideal for customers seeking quality, high-performance solutions in wound care notes Avery Dennison Medical.

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.